Universal Health Realty Income Trust is a healthcare REIT... Show more
Universal Health Realty Income Trust occupies a specialized niche within the healthcare REIT landscape, owning a diversified portfolio of roughly 77 properties across 21 states. Its holdings span acute care and behavioral health hospitals, medical office buildings (MOBs), free-standing emergency departments (FEDs), specialty facilities, and childcare centers. This breadth provides some diversification, yet the trust's strategic identity is inseparable from its advisory relationship with Universal Health Services, its external manager and largest tenant group.
The trust's competitive advantage lies in long-duration, inflation-linked leases, many of which carry contractual annual escalators and corporate guarantees from UHS. This structure underpins a consistently high dividend yield and stable funds from operations (FFO, a key REIT earnings metric that adds back non-cash depreciation). However, the medium-term positioning carries a structural trade-off: limited organic growth and a heavier reliance on floating-rate credit-facility debt than larger, investment-grade peers, making the trust comparatively more exposed to interest-rate cycles.
The Miller Medical Plaza development signals a shift toward self-funded expansion and a modest re-rating of the trust's growth profile, even as its small market capitalization constrains acquisition firepower relative to larger healthcare landlords.
Several forward-looking catalysts could reshape investor sentiment in the coming quarters. First, the scheduled 2026 expirations of the McAllen and Wellington hospital leases are the most consequential near-term events. Favorable renewal terms, including rent escalators and extended durations, would reinforce cash-flow visibility, while any delays or unfavorable renegotiations could weigh on the outlook.
Second, completion of the Miller Medical Plaza in Q4 2026 is expected to begin contributing incremental lease revenue, supported by a 10-year master flex lease covering approximately 75% of the space. Successful lease-up of the remaining square footage would add further upside.
Third, balance-sheet actions are worth monitoring. In April 2026, the trust expanded its credit facility from $425 million to $475 million, enhancing liquidity ahead of development funding needs and refinancing activity. Continued proactive interest-rate hedging will also influence net income as swap settlements offset floating-rate costs.
On the analyst front, coverage is unusually thin for a dividend-paying REIT. Freedom Capital Markets initiated coverage in October 2026 with a Buy rating and a $40 price target, while other consensus trackers report a Hold-to-constructive stance with a single-analyst average target near $40 to $44. Given the small sample, these price targets should be viewed as directional rather than definitive.
UHT's trajectory is closely tied to the interest-rate environment. Lower rates would reduce floating-rate borrowing costs, enhance property acquisition economics, and make the trust's high dividend yield more attractive relative to fixed income. Conversely, persistently elevated rates pressure net income and limit external growth.
Demographics remain a structural tailwind: an aging U.S. population supports sustained demand for acute care, behavioral health, and outpatient facilities. Yet regulatory headwinds are material. The "One Big Beautiful Bill Act," which imposes Medicaid work requirements and limits provider fees, plus the December 2025 expiration of enhanced premium tax credits (subsidies that lower insurance costs), could reduce tenant revenues and reimbursement levels, indirectly affecting rent-paying capacity across the healthcare-services sector.
For investors seeking a data-driven view of near-term direction, Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the next week or month. It is designed to help users identify developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad universe of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. Explore the Trend Prediction Engine to complement your own analysis of UHT and the broader healthcare REIT sector.
Looking toward 2026 and beyond, several structural themes will define UHT's future outlook. The completion and stabilization of the Miller Medical Plaza could establish a template for further self-funded development, potentially accelerating the trust's modest growth trajectory. Successful renegotiation of the McAllen and Wellington leases would lock in longer-duration income and reduce near-term vacancy risk.
Cost structure and margin sustainability will hinge on the trust's ability to manage floating-rate debt as hedges roll off, while capital allocation priorities — balancing development spending, debt repayment, and dividend growth — will remain under scrutiny. The dividend, raised in small increments and yielding above 7%, continues to be a core investor appeal, though its coverage by free cash flow rather than FFO warrants monitoring.
Competitive threats include larger, better-capitalized healthcare REITs with greater acquisition capacity, while regulatory shifts around Medicaid and insurance subsidies could alter tenant economics. Consensus expectations remain modestly constructive but are based on limited coverage, underscoring the importance of watching lease events, development milestones, and rate policy as the primary drivers of the stock forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, UHT has been closely correlated with LXP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHT jumps, then LXP could also see price increases.
| Ticker / NAME | Correlation To UHT | 1D Price Change % |
|---|---|---|
| UHT | 100% | +0.16% |
| UHT (2 stocks) | 68% Closely correlated | +0.08% |
| Publishing: Books/Magazines (18 stocks) | 67% Closely correlated | +0.26% |
| Consumer Services (217 stocks) | 37% Loosely correlated | -2.49% |
a real estate investment trust
Industry PublishingBooksMagazines
UHT moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend. In 18 of 28 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UHT as a result. In 45 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for UHT turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 32 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for UHT crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +0.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHT advanced for three days, in 173 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
UHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 92 of 224 cases where UHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. UHT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.777) is normal, around the industry mean (3.134). P/E Ratio (28.137) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (2.840) is also within normal values, averaging (1.649). Dividend Yield (0.077) settles around the average of (0.050) among similar stocks. P/S Ratio (5.705) is also within normal values, averaging (6.013).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.